Mirum Pharmaceuticals (MIRM) Other Gross PP&E Adjustments (2020 - 2025)
Mirum Pharmaceuticals (MIRM) has 6 years of Other Gross PP&E Adjustments data on record, last reported at -$26.0 million in Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments fell 22.68% year-over-year to -$26.0 million; the TTM value through Dec 2025 reached -$26.0 million, down 22.68%, while the annual FY2025 figure was -$26.0 million, 22.68% down from the prior year.
- Other Gross PP&E Adjustments reached -$26.0 million in Q4 2025 per MIRM's latest filing, down from -$21.4 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$4.0 million in Q4 2021 and bottomed at -$26.0 million in Q4 2025.
- Average Other Gross PP&E Adjustments over 5 years is -$12.5 million, with a median of -$9.2 million recorded in 2023.
- Peak YoY movement for Other Gross PP&E Adjustments: increased 1.92% in 2021, then crashed 167.46% in 2024.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$4.0 million in 2021, then tumbled by 68.93% to -$6.8 million in 2022, then crashed by 35.6% to -$9.2 million in 2023, then crashed by 130.03% to -$21.2 million in 2024, then dropped by 22.68% to -$26.0 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$26.0 million in Q4 2025, -$21.4 million in Q3 2025, and -$23.0 million in Q2 2025.